The city's largest private employer had projected as many as a dozen new buildings for its Plymouth Road complex in 2003, but the New York-based company delayed major construction this past year because of its $57-billion acquisition of Pharmacia Corp., which closed in April 2004. Pfizer has not yet submitted exact building plans to the city.
The largest Pfizer project currently under review is a new science facility of 100,000 sf or more, planned for the southern area of the Plymouth Road campus, says Herb Rickloff, executive director of operations for Pfizer's Michigan labs. Local Pfizer officials submitted a request for constructing the building to the company's upper management, which has yet to OK the proposal.
Other possible Pfizer projects in the city for 2004 may include:
* Expanding its on-site power plant at a cost of $44 million to accommodate new growth.
* Upgrading one of the company's largest and oldest administration facilities (called Building 20), to cost $30 million.
* $17.5 million in expansions and technology changes for a drug-prototyping lab.
* Various infrastructure improvements totaling $11 million.
* Adding new magnetic resonance imaging, or MRI, equipment at a cost of $8 million.
The Ann Arbor City Council passed tax abatements two years ago to encourage Pfizer to remain and grow, locally. The abatements require Pfizer to reach a $100-million threshold for new construction by November 2005 in order to reap a 50% tax discount on that and any additional construction up to $800 million.
Want to continue reading?
Become a Free ALM Digital Reader.
Once you are an ALM Digital Member, you’ll receive:
- Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
*May exclude premium content© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.